Rare Disease Consulting
Due to their low occurrence and specific regulatory requirements, rare diseases present unique challenges in treatment development, evidence generation, and commercialization. We have a team with the knowledge and experience to support your decision making at all stages of product development.
Rare disease consulting solutions
Developing and launching new rare disease therapies can pose several unique challenges. We provide the required expertise to help you navigate these barriers.
An expert team to support product development and launch
Our experience in rare diseases spans all stages, from product development, market assessment, and asset prioritization through to real-world evidence generation and consulting support for commercialization. Our global, multidisciplinary team of experts takes a pragmatic, modular, and flexible approach to engagements. We’re proud to have conducted more 600 studies on rare diseases around the world, providing a strong knowledge base for determining study feasibility and optimizing design and execution.
Rich and relevant data from multiple trusted sources
We follow a data-first strategy, combining diverse data sources for deeper insights. Our first step is to determine what existing data is available, which can be very limited for rare diseases. We can also create custom primary studies, databases, or registries using direct-to-patient or site-based methods. Alternatively, we can adopt a hybrid approach, combining new and existing data. Ultimately, our goal is to access or generate the best achievable data for the situation.
Eliciting deep insights with care and sensitivity
To fully understand how decisions are made, you must understand the person behind the patient, caregiver, or healthcare provider. This is particularly true for rare disease research, where sufferers can be young, medical knowledge is often sparse, and the treatment journey is typically quite complex. Our team takes special care to ensure research is conducted sensitively, with empathy and without judgment.
Strong operational skills to reach the relevant stakeholders
Identifying the right stakeholders is key to understanding how a rare disease is diagnosed and treated. We have a proven track record of accessing patients, patient organizations and advocacy groups, caregivers, key opinion leaders, clinicians, and payers. We tailor our recruitment strategies to the needs of the indication to provide the insight and evidence you need for strategic decision-making.
Oracle Life Sciences 入門
聯絡我們
與 Oracle 團隊成員討論我們的生命科學解決方案。
關注我們的播客
聆聽來自製藥、生物技術和 CRO 的科學家、臨床醫生及業界領袖的分享，瞭解他們如何推動生命科學和健康領域的創新。
取得技術支援
瞭解技術支援聯絡人和資源。